ElliottFWintonMD

Hematology • Atlanta, GA

Associate Professor, Hematology and Medical Oncology, Emory University School of Medicine

Join to view full profile

Dr. Winton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Winton's full profile

Already have an account?

Office
1365 Clifton Rd Ne
Atlanta, GA 30322
Phone+1 404-778-1900

Education & Training

Emory University School of MedicineResidency, Internal Medicine, 1973 - 1974
Emory University School of MedicineResidency, Internal Medicine, 1970 - 1973
University of ChicagoInternship, Internal Medicine, 1967 - 1968
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1967

Certifications & Licensure

GA State Medical License 1972 - 2025
OH State Medical License 1968 - 1974
American Board of Internal Medicine Internal Medicine

Clinical Trials

Correlative Biomarker Study in Patients With Myeloproliferative Disorders Start of enrollment: 2007 Apr 01
Completed
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia Start of enrollment: 2011 May 01
Completed
Phase 2
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis Start of enrollment: 2013 Jan 01
Terminated
Phase 2
Ruxolitinib Prior to Transplant in Patients With Myelofibrosis Start of enrollment: 2013 Nov 01
Terminated
Phase 2
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia Start of enrollment: 2014 Jul 08
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

6 citations
Update on myelodysplastic syndromes: New approaches to classification and therapy
Amelia Langston, Radhika Walling, Elliott F. Winton
Seminars in Oncology. 2004-04-01
1456 citations
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta
The New England Journal of Medicine. 2012-03-01
63 citations
Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia
Kim Hien T. Dao, Jason Gotlib, Michael M.N. Deininger, Stephen T. Oh, Jorge E. Cortes
Journal of Clinical Oncology. 2020-04-01

Abstracts/Posters

Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Set...
Elliott F. Winton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Surviving Cancer, Part 1February 9th, 2020
Winship Hematologist Honored as MPN HeroDecember 5th, 2016
Winship to Celebrate 5,000th Bone Marrow Transplant PatientJune 14th, 2016
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member